Tags

Type your tag names separated by a space and hit enter

Can we identify the high-risk patients to be screened? A genetic approach.
Digestion 2007; 76(1):7-19D

Abstract

Our understanding of the mechanisms that lead to colorectal cancer expands each year. Patients with a genetic predisposition to colorectal cancer have significantly increased risks for developing this malignancy over their lifetime. These risks can approach an 80 to nearly 100% likelihood of colorectal malignancy with some of the known cancer predisposition syndromes [Burt and Neklason: Gastroenterology 2005;128:1696-1716 and Rowley: Annu Rev Med 2005;56:539-554]. Although these inherited syndromes have a genetic basis, affected individuals are often initially seen by medical professionals outside the genetics realm. Gastroenterologists in particular have a key role in identifying patients at high risk for an inherited colorectal cancer predisposition syndrome and referring them on for directed genetics evaluation. In this review, we will focus on the presenting features and recommended screening and treatment protocols for six syndromes that predispose to colorectal carcinoma. The underlying genetic basis of each syndrome will be discussed, as well as specific guidelines for patient identification. Familial adenomatous polyposis will be covered first, followed by Lynch syndrome, attenuated familial adenomatous polyposis, MYH-associated polyposis, hereditary mixed polyposis, and hyperplastic polyposis. Other rare syndromes (the hamartomatous polyposis syndromes) will be summarized in table form. Finally, we will give some general guidelines for when to first suspect colorectal cancer syndromes, a summary of family history taking techniques that can be used in the primary care setting and a review of the referral, genetics appointment and postgenetics consultation process. Through this review, we hope to show that the identification of high-risk patients is possible, though sometimes difficult.

Authors+Show Affiliations

Department of Medicine, University of Utah, Salt Lake City, UT 84112-5550, USA. amanda.gammon@hci.utah.eduNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

17947814

Citation

Gammon, Amanda, et al. "Can We Identify the High-risk Patients to Be Screened? a Genetic Approach." Digestion, vol. 76, no. 1, 2007, pp. 7-19.
Gammon A, Kohlmann W, Burt R. Can we identify the high-risk patients to be screened? A genetic approach. Digestion. 2007;76(1):7-19.
Gammon, A., Kohlmann, W., & Burt, R. (2007). Can we identify the high-risk patients to be screened? A genetic approach. Digestion, 76(1), pp. 7-19.
Gammon A, Kohlmann W, Burt R. Can We Identify the High-risk Patients to Be Screened? a Genetic Approach. Digestion. 2007;76(1):7-19. PubMed PMID: 17947814.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Can we identify the high-risk patients to be screened? A genetic approach. AU - Gammon,Amanda, AU - Kohlmann,Wendy, AU - Burt,Randall, Y1 - 2007/10/19/ PY - 2007/10/20/pubmed PY - 2008/1/25/medline PY - 2007/10/20/entrez SP - 7 EP - 19 JF - Digestion JO - Digestion VL - 76 IS - 1 N2 - Our understanding of the mechanisms that lead to colorectal cancer expands each year. Patients with a genetic predisposition to colorectal cancer have significantly increased risks for developing this malignancy over their lifetime. These risks can approach an 80 to nearly 100% likelihood of colorectal malignancy with some of the known cancer predisposition syndromes [Burt and Neklason: Gastroenterology 2005;128:1696-1716 and Rowley: Annu Rev Med 2005;56:539-554]. Although these inherited syndromes have a genetic basis, affected individuals are often initially seen by medical professionals outside the genetics realm. Gastroenterologists in particular have a key role in identifying patients at high risk for an inherited colorectal cancer predisposition syndrome and referring them on for directed genetics evaluation. In this review, we will focus on the presenting features and recommended screening and treatment protocols for six syndromes that predispose to colorectal carcinoma. The underlying genetic basis of each syndrome will be discussed, as well as specific guidelines for patient identification. Familial adenomatous polyposis will be covered first, followed by Lynch syndrome, attenuated familial adenomatous polyposis, MYH-associated polyposis, hereditary mixed polyposis, and hyperplastic polyposis. Other rare syndromes (the hamartomatous polyposis syndromes) will be summarized in table form. Finally, we will give some general guidelines for when to first suspect colorectal cancer syndromes, a summary of family history taking techniques that can be used in the primary care setting and a review of the referral, genetics appointment and postgenetics consultation process. Through this review, we hope to show that the identification of high-risk patients is possible, though sometimes difficult. SN - 1421-9867 UR - https://www.unboundmedicine.com/medline/citation/17947814/Can_we_identify_the_high_risk_patients_to_be_screened_A_genetic_approach_ L2 - https://www.karger.com?DOI=10.1159/000108389 DB - PRIME DP - Unbound Medicine ER -